Evidence map›Paper›PMID 32628945›Full record

ArticlePreventive medicine2020

Relating individual differences in nicotine dependence severity to underpinning motivational and pharmacological processes among smokers from vulnerable populations.

Stephen T Higgins, Michael DeSarno, Danielle R Davis, Tyler Nighbor, Joanna M Streck, Shana Adise, Roxanne Harfmann, Riley Nesheim-Case, Catherine Markesich, Derek Reed and 9 more

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Preventive medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it

0cells of the map it votes in

9citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

Randomized clinical trial examining financial incentives for smoking cessation among mothers of young children and possible impacts on child secondhand smoke exposure.Preventive medicine · 2023
Trial
Leveraging the cigarette purchase task to understand relationships between cumulative vulnerabilities, the relative reinforcing effects of smoking, and response to reduced nicotine content cigarettes.Preventive medicine · 2022
Trial
Changes in Cigarette Consumption With Reduced Nicotine Content Cigarettes Among Smokers With Psychiatric Conditions or Socioeconomic Disadvantage: 3 Randomized Clinical Trials.JAMA network open · 2020
Trial
The Moderating Effect of Physical Activity Between IQOS Smoking and Ventricular Repolarization Parameters in Lebanese University Students.Health science reports · 2026
Article
The electronic nicotine delivery system (ENDS) purchase task: Are results sensitive to price framing?Experimental and clinical psychopharmacology · 2023
Article
Examining the latent factor structure of a hypothetical cigarette purchase task among pregnant women.Experimental and clinical psychopharmacology · 2023
Article
Relating individual differences in the reinforcing value of smoking and dependence severity to nicotine exposure levels in vulnerable populations.Preventive medicine · 2022
Article
Blood Nicotine Predicts the Behavioral Economic Abuse Liability of Reduced-Nicotine Cigarettes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
Article
Behavior change, health, and health disparities 2020: Some current challenges in tobacco control and regulatory science.Preventive medicine · 2020
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Stephen T HigginsVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA. Electronic address: stephen.higgins@uvm.edu.

Michael DeSarnoVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Danielle R DavisVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Tyler NighborVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Joanna M StreckVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Shana AdiseVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Roxanne HarfmannVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Riley Nesheim-CaseVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Catherine MarkesichVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Derek ReedDepartment of Applied Behavioral Science, University of Kansas, Lawrence, KS, USA.

Rachel F TyndaleDepartments of Pharmacology & Toxicology and Psychiatry, University of Toronto, Toronto, ON, Canada.

Diann E GaalemaVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Sarah H HeilVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Stacey C SigmonVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Jennifer W TideyVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA; Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.

Andrea C VillantiVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Dustin LeeBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

John R HughesVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Janice Y BunnVermont Center on Behavior and Health, University of Vermont, Burlington, VT, USA.

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2022

$21.3M

University of Vermont Tobacco Center of Regulatory ScienceU54DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2018 to 2022

$19.4M

Vermont Center on Tobacco Regulatory ScienceP50DA036114 · NIDA · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI HIGGINS, STEPHEN T · 2013 to 2017

$19.1M

NIDA NIH HHS P50 DA036114NIDA NIH HHS U54 DA036114NIGMS NIH HHS P20 GM103644

6 · The paper itself

Abstract

We examined whether elucidating underpinning smoking motivation and related pharmacological processes enhances understanding of nicotine dependence among smokers from vulnerable populations. Data were obtained between Oct, 2016 and Sept, 2019 from 745 adult smokers with co-morbid psychiatric conditions or socioeconomic disadvantage at University of Vermont, Brown University, Johns Hopkins University. Smoking motivation was assessed using the Cigarette Purchase Task (CPT), a behavioral-economic task that models the relative reinforcing value of smoking under varying monetary constraint. Dependence severity was measured using the Heaviness of Smoking Index (HSI), Fagerström Test for Nicotine Dependence total scores (FTND), and FTND total scores minus items 1 and 4 (FTND

Indexed as

Tobacco Use DisorderAdultHumansIndividualityMotivationPharmacological PhenomenaSmokersVulnerable PopulationsCigarette purchase taskCotinineFagerström test for nicotine dependenceHeaviness of smoking indexNicotine dependenceRelative reinforcing valueVulnerable populations

Identifiers

PMID32628945

DOI10.1016/j.ypmed.2020.106189

PMCPMC7680415

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.